Betahistine Use in Patients with History of Stroke

Dosing Considerations

The standard dosage of betahistine for vertigo treatment is 48 mg daily, with a treatment duration of at least 3 months to properly evaluate efficacy, as recommended by the American Academy of Otolaryngology 1
Higher doses (144 mg/day) have not shown significant improvement compared to lower doses (48 mg/day) in high-quality trials for vestibular disorders, according to the American Academy of Neurology 1

Betahistine should be used with caution in patients with asthma and history of peptic ulcer disease, as stated by the American College of Gastroenterology 1, 2
The medication is completely contraindicated in patients with pheochromocytoma, as indicated by the American Heart Association 1, 2
Common side effects of betahistine include headache, balance disorder, nausea, and upper gastrointestinal symptoms, as reported by the American Academy of Family Physicians 1
Patients should be reassessed regularly for improvement or stabilization of symptoms and to monitor for medication intolerance or side effects, as recommended by the American Medical Association 1

When considering betahistine in stroke patients, it's essential to ensure it doesn't interfere with the comprehensive stroke management approach outlined in stroke guidelines, which includes blood pressure management, lipid control, and antiplatelet/anticoagulant therapy as appropriate, according to the American Heart Association 3, 4